-
Psychedelics Firm Optimind Pharma Sustains Growth Plan Rollout With New Acquisition
Friday, October 13, 2023 - 5:04pm | 447Psychedelics therapy provider Optimind Pharma Corp. entered into an acquisition agreement with Wolf Acquisitions 1.0 Corp., an arm's length private British Columbia corporation with investments in the psychedelics industry and one of its wholly-owned subsidiaries. See Also: ...
-
Another Ketamine Therapy Company Goes Public: Optimind Pharma Is Now "OMND" On The CSE
Thursday, August 4, 2022 - 5:02pm | 266Medical cannabis and alternative medicines provider Optimind Pharma Corp. began trading on the Canadian Securities Exchange (CSE) under the ticker symbol "OMND". Despite the company’s primary business being medically-prescribed cannabis, due to its efficacy and safety profile,...